FIVE PRIME THERAPEUTICS INC 4
4 · FIVE PRIME THERAPEUTICS INC · Filed Aug 26, 2014
Insider Transaction Report
Form 4
Kavanaugh William Michael
SVP & Chief Scientific Officer
Transactions
- Award
Employee Stock Option (right to buy)
2014-08-22+15,000→ 15,000 totalExercise: $11.14Exp: 2024-08-21→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]One forty-eighth of the shares underlying the option will vest monthly beginning on September 22, 2014.